Vaginal Mass in 54-Year-Old Patient
A 54-year-old woman presents with a mass in the vagina, and a biopsy is performed. What is your diagnosis?
Managing Side Effects of Estrogen Deprivation in Breast Cancer Patients
This video examines how to manage the side effects of estrogen deprivation in breast cancer patients, including vaginal dryness and hot flashes.
Late Effects of Estrogen Deprivation in Breast Cancer
This video examines the late effects of estrogen deprivation in both younger and older breast cancer patients, including bone thinning, heart disease, and dementia.
Treating Locally Advanced Penile Cancer
This video examines the treatment of locally advanced penile cancer and whether an organ-sparing chemoradiotherapy approach might be an option instead of surgery.
Healthy Lifestyle Extended Survival After Colon Cancer Diagnosis
Patients with stage III colon cancer who maintained a healthy lifestyle had a reduced risk for death and a trend for a lower chance of recurrence.
Review Suggests FDA Should Tighten Regulations on Filtered Cigarettes
Evidence suggests that the inclusion of ventilation in cigarette filters has contributed to the increased rate of lung adenocarcinoma among smokers.
Cytogenetic Abnormalities Do Not Affect Prognosis in Pediatric CML
Chromosomal abnormalities such as a variant t(9;22) translocation do not appear to have significant prognostic impact on children with chronic myeloid leukemia.
Gemcitabine Fails in Early Breast Cancer
Final 10-year follow-up of a large phase III trial showed that adding gemcitabine to anthracycline and taxane-based adjuvant chemotherapy increases toxicity and does not improve disease-free survival in early breast cancer patients.
Prostate Cancer Molecular Subtyping Groups Tumors by Prognosis, Response
Molecular subtyping of prostate cancer into three categories—luminal A, luminal B, and basal—identifies differences in prognosis and response to treatment.
Pembrolizumab Gets New Indications in Advanced Cancer
The FDA has granted approval to pembrolizumab (Keytruda) in the first- and second-line settings for the treatment of patients with locally advanced or metastatic urothelial carcinoma.
By clicking Accept, you agree to become a member of the UBM Medica Community.